181 related articles for article (PubMed ID: 31155753)
1. Resveratrol chemosensitizes adriamycin-resistant breast cancer cells by modulating miR-122-5p.
Zhang W; Jiang H; Chen Y; Ren F
J Cell Biochem; 2019 Sep; 120(9):16283-16292. PubMed ID: 31155753
[TBL] [Abstract][Full Text] [Related]
2. The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin.
Han B; Huang J; Han Y; Hao J; Wu X; Song H; Chen X; Shen Q; Dong X; Pang H; Cai L
Int J Biol Macromol; 2019 Mar; 125():544-556. PubMed ID: 30537505
[TBL] [Abstract][Full Text] [Related]
3. microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.
Zeng H; Wang L; Wang J; Chen T; Li H; Zhang K; Chen J; Zhen S; Tuluhong D; Li J; Wang S
Arch Biochem Biophys; 2018 Aug; 651():52-60. PubMed ID: 29802821
[TBL] [Abstract][Full Text] [Related]
4. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.
Zhu Y; Wu J; Li S; Ma R; Cao H; Ji M; Jing C; Tang J
Cell Physiol Biochem; 2013; 32(5):1225-37. PubMed ID: 24335172
[TBL] [Abstract][Full Text] [Related]
5. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.
Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB
Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529
[TBL] [Abstract][Full Text] [Related]
8. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
[TBL] [Abstract][Full Text] [Related]
9. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
[TBL] [Abstract][Full Text] [Related]
10. Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.
Venkatadri R; Muni T; Iyer AK; Yakisich JS; Azad N
Cell Death Dis; 2016 Feb; 7(2):e2104. PubMed ID: 26890143
[TBL] [Abstract][Full Text] [Related]
11. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
Zhong S; Li W; Chen Z; Xu J; Zhao J
Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
[TBL] [Abstract][Full Text] [Related]
12. miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin.
Wang M; Cai WR; Meng R; Chi JR; Li YR; Chen AX; Yu Y; Cao XC
Biochem Biophys Res Commun; 2018 Jun; 501(1):48-54. PubMed ID: 29678577
[TBL] [Abstract][Full Text] [Related]
13. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
15. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
16. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells.
Hu Q; Gong JP; Li J; Zhong SL; Chen WX; Zhang JY; Ma TF; Ji H; Lv MM; Zhao JH; Tang JH
Asian Pac J Cancer Prev; 2014; 15(13):5137-42. PubMed ID: 25040964
[TBL] [Abstract][Full Text] [Related]
18. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
[TBL] [Abstract][Full Text] [Related]
19. miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2.
Zhang Y; Xia F; Zhang F; Cui Y; Wang Q; Liu H; Wu Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):26. PubMed ID: 30665445
[TBL] [Abstract][Full Text] [Related]
20. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
